Effectiveness of nirmatrelvir/ritonavir and molnupiravir in reducing the risk of short-term and long-term cardiovascular complications of COVID-19: a target trial emulation study

Journal:

Nature Communications

Published:

2025-12-21

DOI:

10.1038/s41467-025-67776-4

Affiliations:

9

Authors:

17

Go to article

Institutions	Authors	Share
The Chinese University of Hong Kong (CUHK), China	12.750000 12.750000	0.75
Harvard University, United States of America (USA)	1.000000	0.06
Cleveland Clinic Lerner College of Medicine of Case Western Reserve University (CCLCM), United States of America (USA)	1.000000	0.06
Duke-NUS Medical School, Singapore	1.000000	0.06
Tianjin Medical University (TMU), China	1.000000	0.06
City University of Hong Kong (CityU), China	0.250000	0.01

Interested in Medical Microbiology?